Plasma endothelin levels and surgically correctable pulmonary hypertension

Hang Chang, Gong Jhe Wu, Shih Ming Wang, Chi Ren Hung

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

To know the changes in plasma endothelin of patients with pulmonary hypertension, we studied 32 patients with valvular heart disease. Among them, 22 patients had pulmonary hypertension (group I) and 10 had pulmonary arterial pressures in the normal range (group II). Plasma endothelin-1 concentrations of the patients in group I were significantly greater than those of the patients in group II (p <0.05). No significant difference in plasma endothelin-3 concentrations existed between the two groups. Cardiac output and pulmonary capillary wedge pressure had a linear correlation with plasma endothelin-1 levels. There was also a significant correlation between plasma endothelin-1 levels and hemodynamic indicators of severity of pulmonary hypertension, such as mean pulmonary arterial pressure and pulmonary vascular resistance (p <0.05). All patients in this study underwent surgical procedures for the correction of valvular lesions. All patients in group I showed a decrease in pulmonary arterial pressures, and their plasma endothelin-1 levels decreased from 3.84 ± 0.20 pg/mL to 1.66 ± 0.07 pg/mL (p <0.05), whereas the plasma endothelin-3 levels had only slight variation from 0.64 ± 0.11 pg/mL to 0.75 ± 0.06 pg/mL (p > 0.05) between the preoperative and the postoperative stages. The results demonstrated that plasma endothelin-1 rather than endothelin-3 had a role in pulmonary hypertension. Several pieces of evidence pointed out that endothelin-1 functioned as a reactive mediator during vasoconstriction in the case of pulmonary hypertension rather than as a triggering factor of pulmonary hypertension.

Original languageEnglish
Pages (from-to)450-458
Number of pages9
JournalAnnals of Thoracic Surgery
Volume55
Issue number2
DOIs
Publication statusPublished - 1993
Externally publishedYes

Fingerprint

Endothelins
Pulmonary Hypertension
Endothelin-1
Endothelin-3
Heart Valve Diseases
Vasoconstriction
Arterial Pressure
Reference Values
Lung

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Plasma endothelin levels and surgically correctable pulmonary hypertension. / Chang, Hang; Wu, Gong Jhe; Wang, Shih Ming; Hung, Chi Ren.

In: Annals of Thoracic Surgery, Vol. 55, No. 2, 1993, p. 450-458.

Research output: Contribution to journalArticle

Chang, Hang ; Wu, Gong Jhe ; Wang, Shih Ming ; Hung, Chi Ren. / Plasma endothelin levels and surgically correctable pulmonary hypertension. In: Annals of Thoracic Surgery. 1993 ; Vol. 55, No. 2. pp. 450-458.
@article{fef83e3ae74147659db50587619974c5,
title = "Plasma endothelin levels and surgically correctable pulmonary hypertension",
abstract = "To know the changes in plasma endothelin of patients with pulmonary hypertension, we studied 32 patients with valvular heart disease. Among them, 22 patients had pulmonary hypertension (group I) and 10 had pulmonary arterial pressures in the normal range (group II). Plasma endothelin-1 concentrations of the patients in group I were significantly greater than those of the patients in group II (p <0.05). No significant difference in plasma endothelin-3 concentrations existed between the two groups. Cardiac output and pulmonary capillary wedge pressure had a linear correlation with plasma endothelin-1 levels. There was also a significant correlation between plasma endothelin-1 levels and hemodynamic indicators of severity of pulmonary hypertension, such as mean pulmonary arterial pressure and pulmonary vascular resistance (p <0.05). All patients in this study underwent surgical procedures for the correction of valvular lesions. All patients in group I showed a decrease in pulmonary arterial pressures, and their plasma endothelin-1 levels decreased from 3.84 ± 0.20 pg/mL to 1.66 ± 0.07 pg/mL (p <0.05), whereas the plasma endothelin-3 levels had only slight variation from 0.64 ± 0.11 pg/mL to 0.75 ± 0.06 pg/mL (p > 0.05) between the preoperative and the postoperative stages. The results demonstrated that plasma endothelin-1 rather than endothelin-3 had a role in pulmonary hypertension. Several pieces of evidence pointed out that endothelin-1 functioned as a reactive mediator during vasoconstriction in the case of pulmonary hypertension rather than as a triggering factor of pulmonary hypertension.",
author = "Hang Chang and Wu, {Gong Jhe} and Wang, {Shih Ming} and Hung, {Chi Ren}",
year = "1993",
doi = "10.1016/0003-4975(93)91018-I",
language = "English",
volume = "55",
pages = "450--458",
journal = "Annals of Thoracic Surgery",
issn = "0003-4975",
publisher = "Elsevier USA",
number = "2",

}

TY - JOUR

T1 - Plasma endothelin levels and surgically correctable pulmonary hypertension

AU - Chang, Hang

AU - Wu, Gong Jhe

AU - Wang, Shih Ming

AU - Hung, Chi Ren

PY - 1993

Y1 - 1993

N2 - To know the changes in plasma endothelin of patients with pulmonary hypertension, we studied 32 patients with valvular heart disease. Among them, 22 patients had pulmonary hypertension (group I) and 10 had pulmonary arterial pressures in the normal range (group II). Plasma endothelin-1 concentrations of the patients in group I were significantly greater than those of the patients in group II (p <0.05). No significant difference in plasma endothelin-3 concentrations existed between the two groups. Cardiac output and pulmonary capillary wedge pressure had a linear correlation with plasma endothelin-1 levels. There was also a significant correlation between plasma endothelin-1 levels and hemodynamic indicators of severity of pulmonary hypertension, such as mean pulmonary arterial pressure and pulmonary vascular resistance (p <0.05). All patients in this study underwent surgical procedures for the correction of valvular lesions. All patients in group I showed a decrease in pulmonary arterial pressures, and their plasma endothelin-1 levels decreased from 3.84 ± 0.20 pg/mL to 1.66 ± 0.07 pg/mL (p <0.05), whereas the plasma endothelin-3 levels had only slight variation from 0.64 ± 0.11 pg/mL to 0.75 ± 0.06 pg/mL (p > 0.05) between the preoperative and the postoperative stages. The results demonstrated that plasma endothelin-1 rather than endothelin-3 had a role in pulmonary hypertension. Several pieces of evidence pointed out that endothelin-1 functioned as a reactive mediator during vasoconstriction in the case of pulmonary hypertension rather than as a triggering factor of pulmonary hypertension.

AB - To know the changes in plasma endothelin of patients with pulmonary hypertension, we studied 32 patients with valvular heart disease. Among them, 22 patients had pulmonary hypertension (group I) and 10 had pulmonary arterial pressures in the normal range (group II). Plasma endothelin-1 concentrations of the patients in group I were significantly greater than those of the patients in group II (p <0.05). No significant difference in plasma endothelin-3 concentrations existed between the two groups. Cardiac output and pulmonary capillary wedge pressure had a linear correlation with plasma endothelin-1 levels. There was also a significant correlation between plasma endothelin-1 levels and hemodynamic indicators of severity of pulmonary hypertension, such as mean pulmonary arterial pressure and pulmonary vascular resistance (p <0.05). All patients in this study underwent surgical procedures for the correction of valvular lesions. All patients in group I showed a decrease in pulmonary arterial pressures, and their plasma endothelin-1 levels decreased from 3.84 ± 0.20 pg/mL to 1.66 ± 0.07 pg/mL (p <0.05), whereas the plasma endothelin-3 levels had only slight variation from 0.64 ± 0.11 pg/mL to 0.75 ± 0.06 pg/mL (p > 0.05) between the preoperative and the postoperative stages. The results demonstrated that plasma endothelin-1 rather than endothelin-3 had a role in pulmonary hypertension. Several pieces of evidence pointed out that endothelin-1 functioned as a reactive mediator during vasoconstriction in the case of pulmonary hypertension rather than as a triggering factor of pulmonary hypertension.

UR - http://www.scopus.com/inward/record.url?scp=0027479305&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027479305&partnerID=8YFLogxK

U2 - 10.1016/0003-4975(93)91018-I

DO - 10.1016/0003-4975(93)91018-I

M3 - Article

C2 - 8431058

AN - SCOPUS:0027479305

VL - 55

SP - 450

EP - 458

JO - Annals of Thoracic Surgery

JF - Annals of Thoracic Surgery

SN - 0003-4975

IS - 2

ER -